ALDEYRA THERAPEUTICS, INC. Long-Term Debt
ALDEYRA THERAPEUTICS, INC. (ALDX) had Long-Term Debt of $0 as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2026-05-07
- 2026-03-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2025-06-30: Long-term Debt, Excluding Current Maturities $0.00.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-12-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $15.10M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $15.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $15.00M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | $2.66M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $10.13M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $14.97M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $14.92M 10-K · filed 2024-03-07 |
| 2022-09-30 | $3.30M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $10.74M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $15.59M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $15.50M 10-K · filed 2023-03-09 |
| 2021-09-30 | $15.42M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $15.34M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $10.14M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $11.43M 10-K · filed 2022-03-17 |
| 2020-09-30 | $12.69M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.92M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.67M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $14.53M 10-K · filed 2021-03-11 |
| 2019-09-30 | $14.39M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $882.84K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $995.29K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.11M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.22M 10-K · filed 2019-03-08 |
| 2017-09-30 | $905.25K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.02M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $1.13M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.24M 10-K · filed 2018-03-29 |
| 2016-09-30 | $883.28K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $992.63K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $1.10M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.21M 10-K · filed 2017-03-30 |
| 2015-09-30 | $1.28M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $961.55K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $1.07M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $1.18M 10-K · filed 2016-03-30 |
| 2014-09-30 | $1.24M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $815.83K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $972.42K 10-Q · filed 2014-06-11 |
| 2013-12-31 | $1.13M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |